Simon Broadley

11.1k total citations · 1 hit paper
108 papers, 3.3k citations indexed

About

Simon Broadley is a scholar working on Pathology and Forensic Medicine, Neurology and Rheumatology. According to data from OpenAlex, Simon Broadley has authored 108 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Pathology and Forensic Medicine, 35 papers in Neurology and 20 papers in Rheumatology. Recurrent topics in Simon Broadley's work include Multiple Sclerosis Research Studies (57 papers), Peripheral Neuropathies and Disorders (21 papers) and Systemic Lupus Erythematosus Research (9 papers). Simon Broadley is often cited by papers focused on Multiple Sclerosis Research Studies (57 papers), Peripheral Neuropathies and Disorders (21 papers) and Systemic Lupus Erythematosus Research (9 papers). Simon Broadley collaborates with scholars based in Australia, United Kingdom and United States. Simon Broadley's co-authors include David Clayton, M. H. C. Williams, Bruce Taylor, Jeannette Lechner‐Scott, Stephen Sawcer, Cullen O’Gorman, Michael Barnett, D. A. S. Compston, Fabienne Brilot and Sudarshini Ramanathan and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Brain.

In The Last Decade

Simon Broadley

99 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination

2017 390 citations Simon Broadley, Jeannette Lechner‐Scott et al. Journal of Neurology Neurosurgery & Psychiatry profile →

Peers

Countries citing papers authored by Simon Broadley

Since Specialization

Citations

This map shows the geographic impact of Simon Broadley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Broadley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Broadley more than expected).

Fields of papers citing papers by Simon Broadley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon Broadley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Broadley. The network helps show where Simon Broadley may publish in the future.

Co-authorship network of co-authors of Simon Broadley

This figure shows the co-authorship network connecting the top 25 collaborators of Simon Broadley. A scholar is included among the top collaborators of Simon Broadley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon Broadley. Simon Broadley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Urbanisation and mental health in left-behind children: systematic review and meta-analysis using resilience framework 2025 ·Pediatric Research ·(unknown), (unknown), (unknown), (unknown), (unknown), Simon Broadley, Jing Sun	0
2	Changes in employment status over time in multiple sclerosis following a first episode of central nervous system demyelination, a Markov multistate model study 2023 ·European Journal of Neurology ·Amin Zarghami, (unknown), Suzi B. Claflin, Ingrid van der Mei, Anne‐Louise Ponsonby, Simon Broadley, Steve Simpson, (unknown), (unknown)	5
3	Effectiveness of telemonitoring intervention on glycaemic control in patients with type 2 diabetes mellitus: A systematic review and meta-analysis 2023 ·Diabetes Research and Clinical Practice ·(unknown), (unknown), (unknown), (unknown), (unknown), Simon Broadley, Jing Sun	3
4	Genetically determined serum serine level has a novel causal effect on multiple sclerosis risk and predicts disability progression 2023 ·Journal of Neurology Neurosurgery & Psychiatry ·Xin Lin, Yuanhao Yang, (unknown), Xianyong Yin, Steve Simpson, Ingrid van der Mei, Simon Broadley, Anne‐Louise Ponsonby, (unknown), Kathryn P. Burdon, Bruce Taylor, Yuan Zhou	2
5	Worldwide Incidence and Prevalence of Neuromyelitis Optica 2020 ·Neurology ·Viktoria Papp, Melinda Magyari, Orhan Aktaş, Thomas Berger, Simon Broadley, Philippe Cabre, Anu Jacob, Jun‐ichi Kira, Maria Isabel Leite, Romain Marignier, Katsuichi Miyamoto, Jacqueline Palace, Albert Saiz, María Sepúlveda, Ólafur Sveinsson, Zsolt Illés	165
6	Efficacy Outcomes in RRMS Patients Who Switched From SC IFNB-1a in CARE-MS I and II to Alemtuzumab in the Extension Studies: 7-Year Follow-up 2020 ·Multiple Sclerosis Journal ·Daniel Pelletier, Douglas L. Arnold, Ann Bass, Alexey Boyко, Simon Broadley, G. Comi, Pamela McCombe, Xavier Montalbán, Carlo Pozzilli, Àlex Rovira, Krzysztof Selmaj, (unknown), P. Vermersch, (unknown), Elizabeth M. Poole, Sibyl Wray	2
7	Study protocol for a randomised, double-blind, placebo-controlled study evaluating the Efficacy of cannabis-based Medicine Extract in slowing the disease pRogression of Amyotrophic Lateral sclerosis or motor neurone Disease: the EMERALD trial 2019 ·BMJ Open ·Berzenn Urbi, Simon Broadley, Richard Bedlack, Ethan B. Russo, Arman Sabet	21
8	Efficacy of alemtuzumab over 6 years in relapsing–remitting multiple sclerosis patients who relapsed between courses 1 and 2: Post hoc analysis of the CARE-MS studies 2019 ·Multiple Sclerosis Journal ·Bart Van Wijmeersch, B. Singer, Aaron Boster, Simon Broadley, Óscar Fernández, Mark S. Freedman, Guillermo Izquierdo, Jan Lycke, Carlo Pozzilli, Basil Sharrack, Brian Steingo, Heinz Wiendl, Sibyl Wray, Tjalf Ziemssen, (unknown), David Margolin, Karthinathan Thangavelu, Patrick Vermersch	16
9	The Effect of Disease Modifying Therapies on Disability Progression in Multiple Sclerosis: A Systematic Overview of Meta-Analyses 2019 ·Frontiers in Neurology ·Suzi B. Claflin, Simon Broadley, Bruce Taylor	48
10	Vitamin D for the treatment of multiple sclerosis: a meta-analysis 2018 ·Journal of Neurology ·Laurie McLaughlin, Laura Clarke, (unknown), Helmut Butzkueven, Bruce Taylor, Simon Broadley	85
11	Neuromyelitis optica spectrum disorder 2017 ·SHILAP Revista de lepidopterología ·Simon Broadley, (unknown), Saman Heshmat, Laura Clarke	1
12	Alemtuzumab Provides Durable Efficacy Over 6 Years in Patients With Active Relapsing-Remitting Multiple Sclerosis and an Inadequate Response to Prior Therapy in the Absence of Continuous Treatment (CARE-MS II) (S24.006) 2017 ·Neurology ·Edward Fox, David Brassat, Raed Alroughani, Simon Broadley, Jeffrey Cohen, Hans‐Peter Hartung, Eva Havrdová, Celia Oreja‐Guevara, Krzysztof Selmaj, B. Singer, Patrick Vermersch, Sibyl Wray, David Margolin, Karthinathan Thangavelu, Madalina Chirieac, Alasdair Coles	2
13	Enhancing cognitive-behavioural therapy for recurrent headache: design of a randomised controlled trial 2014 ·BMC Neurology ·Paul R. Martin, (unknown), (unknown), (unknown), Simon Broadley, John Reece, Peter J. Goadsby	4
14	Genetic Susceptibility to Multiple Sclerosis: Modelling the Risk with Family Data and Exploring the Effects of Latitude (P05.129) 2013 ·Neurology ·Cullen O’Gorman, Rui Lin, Jim Stankovich, Simon Broadley	1
15	Autoimmune Thyroid Disease in the Use of Alemtuzumab for Multiple Sclerosis: A Review 2013 ·Endocrine Practice ·(unknown), (unknown), (unknown), Simon Broadley, Peter Davoren	22
16	A Transcription Factor Map as Revealed by a Genome-Wide Gene Expression Analysis of Whole-Blood mRNA Transcriptome in Multiple Sclerosis 2010 ·PLoS ONE ·Carlos Riveros, (unknown), Kaushal Gandhi, Fiona C. McKay, Mathew Cox, Regina Berretta, (unknown), Mario Inostroza-Ponta, Simon Broadley, Robert Heard, Steve Vucic, Graeme J. Stewart, David W. Williams, Rodney J. Scott, Jeannette Lechner‐Scott, David R. Booth, Pablo Moscato	46
17	Elevated serum concentrations of troponin T in acute stroke: What do they mean? 2009 ·Journal of Clinical Neuroscience ·Joanna R. Ghali, (unknown), Timothy Kleinig, (unknown), (unknown), Dale T. Ashby, James Taylor, Philip D. Thompson, Simon Broadley	8
18	Predictors of prolonged dysphagia following acute stroke 2003 ·Journal of Clinical Neuroscience ·Simon Broadley, David Croser, Jeremy J. Cottrell, (unknown), (unknown), (unknown), (unknown), Jamie Taylor, Philip D. Thompson	112
19	The clinical and MRI correlate of ischaemia in the ventromedial midbrain: Claude's syndrome 2001 ·Journal of Neurology ·Simon Broadley, Bruce Taylor, Heather Waddy, Peter Thompson	3
20	No association between multiple sclerosis and the Notch3 gene responsible for cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) 2001 ·Journal of Neurology Neurosurgery & Psychiatry ·Simon Broadley	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact